NASDAQ: TRAW
Traws Pharma Inc Earnings Dates, Reports, Calls

Traws Pharma earnings were -$54.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TRAW earnings report on Dec 31, 2024 announced Q4 2024 earnings of $81.9M, down 1,066.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRAW reported annual earnings of -$54.7M, with 188.5% growth.

TRAW earnings history

Current Revenue
$226.0k
Current Earnings
-$54.7M
Current Profit Margin
-24,192%

TRAW Return on Equity

Current Company
N/A
Current Industry
-2%
Current Market
34.1%

TRAW undefined

Current Company
-309.1%
Current Industry
-0.4%
TRAW is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TRAW announces earnings.

TRAW undefined

Current Company
-407.13%
Current Industry
5.9%
TRAW's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRAW vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TRAW-$54.66M-$54.67MN/A-$35.21
JBIO-$48.65M-$48.96MN/A-$59.50
PMCB$20.25M$12.04MN/A$0.74
IBO-$22.49M-$24.71MN/A-$2.30
EVGN-$10.63M-$16.49MN/A-$2.89

Traws Pharma Earnings Reports & History FAQ

What were Traws Pharma's earnings last quarter?

On TRAW's earnings call on Invalid Date, Traws Pharma (NASDAQ: TRAW) reported Q4 2024 earnings per share (EPS) of $95.66, up 2,020.88% year over year. Total TRAW earnings for the quarter were $81.93 million. In the same quarter last year, Traws Pharma's earnings per share (EPS) was -$4.98.

If you're new to stock investing, here's how to buy Traws Pharma stock.

Is Traws Pharma profitable or losing money?

As of the last Traws Pharma earnings report, Traws Pharma is currently losing money. Traws Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$54.67 million, a 188.55% increase year over year.

What was TRAW's earnings growth in the past year?

As of Traws Pharma's earnings date in Invalid Date, Traws Pharma's earnings has grown year over year. TRAW earnings in the past year totalled -$54.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.